Flagship Pioneering Inc. - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 47 filers reported holding SIGILON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Flagship Pioneering Inc. ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$9,645,480
+165.7%
10,370,3690.0%0.38%
+223.3%
Q4 2022$3,629,629
-30.0%
10,370,3690.0%0.12%
-46.8%
Q3 2022$5,185,000
-39.8%
10,370,3690.0%0.22%
-32.7%
Q2 2022$8,608,000
-43.5%
10,370,3690.0%0.32%
-9.5%
Q1 2022$15,245,000
-46.7%
10,370,3690.0%0.36%
-19.2%
Q4 2021$28,622,000
-51.2%
10,370,3690.0%0.44%
-27.9%
Q3 2021$58,592,000
-47.3%
10,370,3690.0%0.61%
-56.8%
Q2 2021$111,274,000
-52.0%
10,370,3690.0%1.42%
-61.7%
Q1 2021$231,778,000
-53.5%
10,370,3690.0%3.71%
-59.1%
Q4 2020$498,089,00010,370,3699.07%
Other shareholders

There were no reported owners of SIGILON THERAPEUTICS INC in Q3 2021.

NameSharesValueWeighting ↓
View complete list of SIGILON THERAPEUTICS INC shareholders